Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis Source: Eur Respir J , 49 (4) 1602215; DOI: 10.1183/13993003.02215-2016 Year: 2017
The use of the lytic D29 mycobacteriophages for accelerated determination of the drug sensitivity of tuberculosis mycobacteria to first and second-line anti-TB drugs in clinical isolates obtained after initial cultivation Source: Virtual Congress 2020 – Tuberculosis: part 2 Year: 2020
Rapid resistance detection of Mycobacterium tuberculosis to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system. Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008
Evaluation of a line probe assay kit for direct and simultaneous detection of mycobacterium tuberculosis complex and its resistance to rifampin Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Colorimetric assays for rapid drug susceptibility testing of Mycobacterium tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 167s Year: 2003
Evaluation of antituberculous drugs administration Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Comparison of the efficacy of two methods of treatment, standard and modified, on patients with Isoniazid resistant tuberculosis Source: Annual Congress 2007 - Difficult tuberculosis cases II Year: 2007
Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay Source: Eur Respir J 2013; 41: 1163-1171 Year: 2013
Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid Source: Eur Respir J, 56 (4) 2000803; 10.1183/13993003.00803-2020 Year: 2020
Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005
Resazurin microtitre assay (REMA) plate – A simple, rapid and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
Application of next-generation sequencing to detect MTB resistance to first- and second-line anti-TB drugs Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Evaluation of therapeutic response in isoniazid resistant TB Source: Eur Respir J 2006; 28: Suppl. 50, 846s Year: 2006
Evaluation of a rapid bactriophage assay for the detection of mycobacterium tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Comparison of rapid in-house methods for drug susceptibility testing of mycobacterium tuberculosis with gold standards Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Evaluation of patient adherence to tuberculosis treatment by measuring drug metabolites in urine Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004
Side effects of antituberculosis drugs in treatment of patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 197s Year: 2007
Minimum inhibitory concentrations (MIC) determination of TB drugs and broad-spectrum antibiotics in M.tuberculosis with M/X/TDR Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005